Gentiva(R) Health Services to Present March 3rd at Raymond James' 29th Annual Institutional Investors Conference in Orlando

MELVILLE, N.Y., Feb. 22 /PRNewswire-FirstCall/-- Gentiva Health Services, Inc. NASDAQ: GTIV, the nation's leading provider of comprehensive home health and related services, announced today that it is scheduled to present from 3:25 p.m. to 3:55 p.m. ET, Monday, March 3, 2008 at the 29th Annual Raymond James Institutional Investors Conference in Orlando, Florida.

The event will be available to the public via a live audio web cast, which may be accessed by visiting http://investors.gentiva.com/events.cfm to register for the live event or listen to the archived version. Visitors to this site will also be able to request advance notifications of this and other upcoming Gentiva events.

Gentiva executives will give attendees an overview of Gentiva's operations and strategic priorities, and review opportunities for growth as the U.S. home health industry provides more services to an aging population.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health and related services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix(R), which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-G

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others: the Company's ability to successfully execute its growth strategy; the impact of significant indebtedness on the Company's liquidity and its ability to meet the requirements of its creditors; general economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to implementation of new business systems, or due to natural disasters or terrorist acts; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 31, 2006.

     Financial and Investor Contact:      John R. Potapchuk
                                          631-501-7035
                                          john.potapchuk@gentiva.com

     Media Contact:                       David Fluhrer
                                          631-501-7102
                                          516-589-0778
                                          david.fluhrer@gentiva.com